The World Health Organization (WHO) has declared that the Zika Virus is a "Global Public Health Emergency" in the Americas in 2016.
(Reuters 02/01/16)

JAJ International is a leading rapid diagnostics manufacturer currently working on a rapid diagnostic for the Zika virus. Currently there is no vaccine or cure for victims, but a quick and accurate diagnostic would allow early diagnosis and more effective treatment. JAJ has developed a Prototype Zika Virus Rapid Diagnostic Test, and we are seeking organizations and government partners that would be able to provide testing and Clinical Data collection.

Our diagnostic works by using immobilized antigens on a membrane that bind the Immunoglobin B or G antibodies of the Zika virus. The test is a one-step rapid diagnostic test that has an unmatched shelf life and is incredibly temperature tolerant, meaning that it can be used in a variety of environments and conditions around the globe, including the heat and humidity of the Amazon jungle. Our rapid test diagnostics are designed that even a layman could use the test with minor instruction.

Brazil and other Latin American countries are doing their best to combat the effects of the Zika virus, but unfortunately there is no known cure and no existing rapid diagnostic tests. El Salvador has even urged citizens to delay conceiving until 2018.

Often misdiagnosed, 80% of Zika infected patients often do not show any symptoms. Common symptoms of Zika include fever, rash, joint pain, and conjunctivitis. In many Latin American countries, these symptoms could easily be confused for other mosquito borne diseases such as Malaria, Dengue Fever, or Chikungunya. Rapid and early diagnosis of the Zika virus would allow for specific and targeted treatment, specifically for pregnant women and their unborn children. There is wide held concern that Zika virus potentially is the cause for a diabilitating birth defect known as Microcephaly. It is extremely devastating for babies born with Microcephaly as there is no known cure, and the potential exists for poor neural developement, life long disability and even death.

President Obama emphasized the need to accelerate research efforts to make available better diagnostic tests, to develop vaccines, and therapuetics. "National Institutes of Health (NIH) Director Dr. Francis Collins cited a Lancet study published Jan. 14 in which researchers predicted the Zika virus could be spread in areas along the East and West Coasts of the United States and much of the Midwest during warmer months, where about 200 million people live." (Reuters 01/26/16).

Once our Zika rapid test becomes certified for production, JAJ will also provide a 4-in-1 Combination test of Zika, Malaria, Dengue Fever, and Chikungunya to assist doctors in tropical regions.

We are committed to preserving the health and safety of the world, and want to help prevent what could be a future epidemic. JAJ International is currently seeking partners to collaborate in the clinical testing and product development of this important diagnostic.

These tests are stricly for R&D and Investigational Use only.